CI Health Care Giants Covered Call ETF (Unhedged)

Fund Overview

The ETF's investment objectives are to provide holders, through an actively managed portfolio, with (i) regular cash distributions, (ii) the opportunity for capital appreciation by investing on an equal weight basis in a portfolio of equity securities of at least the 20 largest health care companies measured by market capitalization listed on a North American stock exchange, and (iii) lower overall volatility of returns on the portfolio than would be experienced by owning a portfolio of securities of such issuers directly, by employing a covered call option writing program. The issuers included in the portfolio, which are based on their market capitalization, may be adjusted based on the Portfolio Manager's view on the liquidity of the issuers' equity securities and their related call options.


FHI.B 8.85%12.10%15.54%25.30%25.30%15.59%14.23%14.55%
As at: 31 Dec 2021 - Benchmark: S&P 500 Health Care Index (Unhedged)


Historical NAVs

Sector Breakdown

As at November 30, 2021

The indicated rates of return are the historical annual compounded total returns, including changes in unit value and do not take into account sales, redemption or optional charges or income taxes payable by a security holder that would have reduced returns.

S&P 500 Health Care Index is a market capitalization weighted index. The constituents of the Index are a subset of the constituents of the S&P 500 Index that have been classified as part of the health care sector according to the Global Industry Classification Standard.

Key Facts

Fund Characteristics

Price/Earnings Ratio21.14
Price/Book Ratio4.15
As at 30 Nov, 2021

Fund Statistics

P/S Ratio (TTM) (Long)1.83
P/C Ratio (TTM) (Long)13.59
ROA % (TTM) (Long)7.97
ROE % (TTM) (Long)26.79
As at 30 Nov, 2021

Number of securities: 40

Asset Allocation

Security Type%
Foreign Stock100.00%


NameSecurity TypeISINTicker %
CIGNA CORP Foreign StockUS1255231003 CI US 5.50
MERCK & CO INC Foreign StockUS58933Y1055 MRK US 5.33
BRISTOL-MYERS SQUIBB CO Foreign StockUS1101221083 BMY US 5.25
AMGEN INC Foreign StockUS0311621009 AMGN US 5.22
CVS HEALTH CORP Foreign StockUS1266501006 CVS US 5.14
ABBVIE INC Foreign StockUS00287Y1091 ABBV US 5.13
MEDTRONIC PLC Foreign StockIE00BTN1Y115 MDT US 5.13
BECTON DICKINSON AND CO Foreign StockUS0758871091 BDX US 5.13
ANTHEM INC Foreign StockUS0367521038 ANTM US 5.09
STRYKER CORP Foreign StockUS8636671013 SYK US 5.06
JOHNSON & JOHNSON Foreign StockUS4781601046 JNJ US 4.92
HCA HEALTHCARE INC Foreign StockUS40412C1018 HCA US 4.76
UNITEDHEALTH GROUP INC Foreign StockUS91324P1021 UNH US 4.75
GILEAD SCIENCES INC Foreign StockUS3755581036 GILD US 4.73
PFIZER INC Foreign StockUS7170811035 PFE US 4.57
ELI LILLY & CO Foreign StockUS5324571083 LLY US 4.55
ABBOTT LABORATORIES Foreign StockUS0028241000 ABT US 4.52
DANAHER CORP Foreign StockUS2358511028 DHR US 4.50
ZOETIS INC Foreign StockUS98978V1035 ZTS US 4.33
JNJ US CALL 175 01/21/22 JOHNSON & JOHNSON (22/01/2022) Option 0.00
ABT US CALL 145 01/21/22 ABBOTT LABORATORIES (22/01/2022) Option 0.00
UNH US CALL 500 01/21/22 UNITEDHEALTH GROUP INC (22/01/2022) Option 0.00
PFE US CALL 60 01/21/22 PFIZER INC (22/01/2022) Option 0.00
ZTS US CALL 240 01/21/22 ZOETIS INC (22/01/2022) Option 0.00
GILD US CALL 75 01/21/22 GILEAD SCIENCES INC COM (22/01/2022) Option 0.00
DHR US CALL 320 01/21/22 DANAHER CORP (22/01/2022) Option 0.00
TMO US CALL 660 01/21/22 THERMO FISHER SCIENTIFIC (22/01/2022) Option 0.00
ABBV US CALL 135 01/21/22 ABBVIE INC (22/01/2022) Option 0.00
LLY US CALL 270 01/21/22 ELI LILLY & CO (22/01/2022) Option 0.00
CVS US CALL 105 01/21/22 CVS CAREMARK CORP (22/01/2022) Option 0.00
HCA US CALL 260 01/21/22 HCA HOLDINGS INC (22/01/2022) Option 0.00
SYK US CALL 260 01/21/22 STRYKER CORP (22/01/2022) Option 0.00
ANTM US CALL 450 01/21/22 ANTHEM INC CLL (22/01/2022) Option 0.00
MDT US CALL 105 01/21/22 MEDTRONIC PLC (22/01/2022) Option 0.00
AMGN US CALL 225 01/21/22 AMGEN INC (22/01/2022) Option 0.00
BDX US CALL 260 01/21/22 BECTON DICKINSON AND CO (22/01/2022) Option 0.00
BMY US CALL 62.5 01/21/22 BRISTOL-MYERS SQUIBB CO (22/01/2022) Option 0.00
MRK US CALL 77.5 01/21/22 MERCK & CO INC (22/01/2022) Option 0.00
CI US CALL 230 01/21/22 CIGNA CORPORATION COM (22/01/2022) Option 0.00
US DOLLAR Currency Security 0.00

As at: 20 January 2022
Holdings are subject to change



Distribution details (.csv)

Twelve month trailing distribution yield : 7.70% (as at 20 Jan 2022)

FHI.BTotalCashReinvestedEligible dividendsNon eligible dividendsOther incomeCapital GainsReturn of capitalForeign IncomeForeign tax paid
2021 +$0.92230$0.92230--------
2020 +$1.03470$1.03470----$0.20445$0.55413$0.32248$0.04636
2019 +$0.60530$0.60530-----$0.45965$0.17135$0.02570
2018 +$0.23130$0.23130----$0.20669$0.02461--

(1) Future distribution dates may be amended at any time. (2) Reinvested distributions are not paid in cash but instead remain invested in the Fund. To recognize that these distributions have been allocated to investors for tax purposes the amounts of these distributions should be added to the adjusted cost base of the units held. (3) The characterization of distributions for tax purposes (such as dividends/other income/capital gains etc.) will not be known for certain until after the Fund's tax year end. Therefore investors will be informed of the characterization of the amounts distributed for tax purposes only for the entire year and not with each distribution. For tax purposes these amounts will be reported by brokers on official tax statements.


6 Oct 2020 Global health-care ETFs provide defence, diversification Investment Executive | Rudy Luukko
13 Jun 2018 First Asset unveils healthcare ETF Wealth Professional | Leo Almazora


22 Apr, 2021 - ETF Facts

National Instrument 81-106 Investment Fund Continuous Disclosure requires disclosure of the proxy voting record on an annual basis for the period ending on June 30 of each year. The proxy voting record must be posted on the website no later than August 31 of each year.

Canadian securities law provides that the manager of an investment funds (in this case, CI Investments Inc. ("CI")), acting on behalf of the investment fund, has the right and obligation to vote proxies relating to the investment fund's portfolio securities. As a practical matter, CI delegates this function to the applicable portfolio manager or sub-adviser, as part of the portfolio manager's or sub-adviser's general management of the investment fund assets, subject to oversight by CI. CI generally requires that applicable portfolio managers or sub-advisers vote all proxies in the best interest of CI's funds and their securityholders, as determined solely by the portfolio manager or sub-adviser, and subject to CI's proxy voting policy, the guidelines applicable to the individual portfolio manager or sub-adviser, and applicable legislation. Portfolio managers and sub-advisers are generally expected to vote on any matter for which the investment fund receives proxy materials for a meeting of securityholders of an issuer.

Proxy voting record for the most recent year:

30 Jun, 2020 - Proxy Voting Record

Warning: Documents posted on this website (including, without limitation, prospectuses) are current only as of the date on them

To access the SEDAR filings of CI Health Care Giants Covered Call ETF (Unhedged) please click here